Table 1. Baseline clinical characteristics, blood examination and UCG findings between the two groups.
| Parameters | LVT group, n=25 | Control group, n=242 | P |
|---|---|---|---|
| Baseline clinical characteristics | |||
| Age (y) | 66.64±2.62 | 68.43±0.74 | 0.46 |
| Male sex | 23 (92.00%) | 194 (80.17%) | 0.15 |
| BMI (kg/m2) | 23.13±1.51 | 23.10±0.45 | 0.99 |
| Smoker | 10 (40.00%) | 67 (27.69%) | 0.20 |
| Hypertension | 16 (64.00%) | 124 (51.24%) | 0.22 |
| Diabetes mellitus | 6 (24.00%) | 69 (28.51%) | 0.63 |
| Hyperlipemia | 1 (4.00%) | 6 (2.48) | 0.69 |
| HR at presentation (bpm) | 67.30±3.99 | 75.75±1.12 | 0.09 |
| Blood examinations on admission | |||
| HbA1C (%) | 6.73±0.32 | 6.42±0.13 | 0.44 |
| TG (mg/dL) | 1.07±0.06 | 1.12±0.04 | 0.66 |
| TC (mg/dL) | 3.97±0.24 | 3.86±0.08 | 0.67 |
| LDL-C (mg/dL) | 2.60±1.17 | 2.49±0.07 | 0.65 |
| HDL-C (mg/dL) | 1.16±0.07 | 1.10±0.03 | 0.50 |
| Creatinine (mg/dL) | 104.59±8.29 | 82.59±6.18 | 0.26 |
| Platelets (×109) | 195.64±20.49 | 206.34±5.10 | 0.53 |
| PT (s) | 13.94±0.66 | 13.06±0.24 | 0.27 |
| Baseline INR | 1.26±0.10 | 1.16±0.06 | 0.58 |
| D-dimer (mg/L) | 4.32±1.22 | 0.85±0.07 | <0.05 |
| Fibrinogen (g/L) | 3.16±0.28 | 3.09±0.07 | 0.79 |
| FDP (μg/mL) | 9.85±3.32 | 4.12±0.60 | 0.05 |
| hs-CRP (mg/L) | 26.93±11.76 | 15.71±2.52 | 0.18 |
| TNT (ng/mL) | 1.51±0.57 | 1.49±0.42 | 0.99 |
| CK-MB (ng/mL) | 7.39±2.17 | 9.90±1.71 | 0.67 |
| MYO (ng/mL) | 139.43±46.67 | 90.02±15.40 | 0.36 |
| BNP (ng/mL) | 4,898.25±1,229.07 | 3,878.90±315.42 | 0.33 |
| Echocardiography | |||
| LVEDD (mm) | 55.43±2.15 | 53.16±1.01 | 0.30 |
| LVESD (mm) | 40.77±2.30 | 42.17±1.56 | 0.61 |
| LVEF (%) | 38.56±1.86 | 38.19±0.35 | 0.85 |
| LV aneurysm | 13 (52.00%) | 23 (9.50%) | <0.01 |
BMI, body mass index; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; PT, prothrombin time; FDP, fibrin degradation products; TNT, troponin T; CK-MB, creatinine kinase MB isoenzyme; MYO, myoglobin; BNP, brain natriuretic peptide; LVEDD, left ventricular end-diastolic dimension; LVESD, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction.